Designed by
Title
Golimumab monoclonal antibody drug. Targets TNF-alpha. Indications for use include rheumatoid arthritis, psoriatic arthritis, #186820625
Description
Golimumab monoclonal antibody drug. Targets TNF-alpha. Indications for use include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. Generic name and stylized antibody representation